Certain information has been excluded pursuant to Regulation S-K, Item 601(b)(10)(iv) from this document because it is both not material and is the type that the registrant treats as private or confidential. ASSET PURCHASE AGREEMENT by and among...Asset Purchase Agreement • May 15th, 2024 • VBI Vaccines Inc/Bc • Pharmaceutical preparations
This Asset Purchase Agreement (this “Agreement”) is made as of February 13, 2024 (the “Agreement Date”), by and among (a) SciVac Ltd., an Israeli company (“Seller”) (b) an Israeli company to be formed as a subsidiary of Brii Cayman following the Agreement Date in accordance with Section 6.13 (“Purchaser”), (c) VBI Vaccines Inc., a company organized under the laws of the province of British Columbia, Canada (“Guarantor”) and (d) Brii Biosciences, Inc., a Delaware Corporation (“Purchaser Guarantor”). Each of Seller and Purchaser is sometimes referred to herein individually as a “Party” and collectively as the “Parties.”
STRATEGIC INNOVATION FUND AMENDMENT AGREEMENT NO. 2VBI Vaccines Inc/Bc • May 15th, 2024 • Pharmaceutical preparations
Variation Biotechnologies Inc., a corporation duly incorporated under the laws of Canada, having its head office located at 310 Hunt Club Road Suite 201, Ottawa, Ontario K1V 1C1.
LETTER AGREEMENTLetter Agreement • May 15th, 2024 • VBI Vaccines Inc/Bc • Pharmaceutical preparations • New York
This LETTER AGREEMENT (the “Agreement”) is entered into as of February 13, 2024 (the “Effective Date”) between VBI VACCINES INC., a British Columbia corporation (“VBI”) and BRII BIOSCIENCES LIMITED, a Cayman Islands company (“Brii” and together with VBI, each a “Party” and together the “Parties”). Capitalized terms not otherwise defined herein shall have the meanings set forth in the License Agreement (as defined below).
FOURTH AMENDMENT TO LOAN AND GUARANTY AGREEMENT, WAIVER AND FORBEARANCE AGREEMENTLoan and Guaranty Agreement, Waiver and Forbearance Agreement • May 15th, 2024 • VBI Vaccines Inc/Bc • Pharmaceutical preparations
This FOURTH AMENDMENT TO LOAN AND GUARANTY AGREEMENT, WAIVER AND FORBEARANCE AGREEMENT (this “Amendment”) is entered into as of February 13, 2024 (the “Fourth Amendment Effective Date”), by and among VARIATION BIOTECHNOLOGIES INC., a Canadian federal corporation (“VBI Cda”, and in its capacity as borrower representative, “Borrower Representative”), VBI VACCINES INC., a British Columbia corporation (“Parent”, and together with Borrower Representative, and any other Person from time to time party to the Agreement (as defined below) as a borrower, collectively, “Borrowers”, and each, a “Borrower”), each of the parties set forth on the signature page hereto as guarantors (together with any other Person from time to time party to the Agreement as a guarantor, collectively, “Guarantors” and each, a “Guarantor”), the lenders party hereto (together with any other lender from time to time under the Agreement, collectively, “Lenders”, and each, a “Lender”) constituting Required Lenders (as defin
PURCHASE AGREEMENTPurchase Agreement • May 15th, 2024 • VBI Vaccines Inc/Bc • Pharmaceutical preparations • Delaware
This PURCHASE AGREEMENT (“Purchase Agreement”) is entered into as of 13 February, 2024 (the “Effective Date”) between, VBI VACCINES, INC. a company organized under the laws of the Province of British Columbia, Canada, and VARIATION BIOTECHNOLOGIES INC., a Canadian federal corporation (together, “VBI”), and each having a principal place of business at 310 Hunt Club Road, Suite 201, Ottawa ON K1V 1C1, and BRII BIOSCIENCES LIMITED, an exempted company organized under the laws of the Cayman Islands (“Brii Bio”), and having a place of business at One City Center, Suite 5-110, 110 Corcoran Street, Durham, NC 27701.
